Literature DB >> 33122572

Inflammation reduces osteoblast cytotoxicity induced by diclofenac: An in vitro study.

José Aguirre1, John M Bonvini, Barbara Rupnik, Claudio Camponovo, Andrea Saporito, Alain Borgeat.   

Abstract

BACKGROUND: Diclofenac and other NSAIDs are routinely used in the postoperative period. Their effect on fracture healing remains unclear and controversial.
OBJECTIVE: The primary outcome was to assess the potential cytotoxicity of clinically relevant concentrations of diclofenac on human osteoblasts.
DESIGN: Laboratory in vitro study.
SETTING: Institute of Physiology, Zurich, Center for Integrative Human Physiology, University of Zurich. MATERIALS: Monolayers of human osteoblasts.
INTERVENTIONS: Exposure of human osteoblast monolayers to several concentrations of diclofenac, for different periods of time, with and without an artificially induced inflammatory process. MAIN OUTCOME MEASURES: Cell count, cell viability, cell proliferation and apoptosis.
RESULTS: A concentration-mediated, time and exposure dependent cytotoxic effect of diclofenac-mediated apoptosis was observed. Stimulated inflammatory conditions seemed to reduce toxic effects.
CONCLUSION: Cytotoxic effects of diclofenac are exposure, time and concentration dependent. Simulating aspects of inflammatory conditions seems to increase resistance to diclofenac cytotoxicity, especially in the presence of higher concentration and longer exposure time.
Copyright © 2020 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33122572     DOI: 10.1097/EJA.0000000000001363

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  1 in total

1.  MSN@IL-4 Sustainingly Mediates Macrophagocyte M2 Polarization and Relieves Osteoblast Damage via NF-κB Pathway-Associated Apoptosis.

Authors:  Cheng Shi; Fei Yuan; Zhilong Li; Zhenhua Zheng; Changliang Yuan; Ziyang Huang; Jianping Liu; Xuping Lin; Taoyi Cai; Guofeng Huang; Zhenqi Ding
Journal:  Biomed Res Int       Date:  2022-10-03       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.